Pharma Excipients

News on Pharma Excipients

Drug-Based Reversal of Drug Resistance in Hepatocellular Carcinoma (HCC) Using TPGS

Abstract Hepatocellular carcinoma (HCC) is a cancer with high incidence and mortality rates worldwide. In the various treatment methods for HCC, the lack of cancer cell specificity and the development of multidrug resistance (MDR) are two major obstacles in the treatment of HCC. P-glycoprotein (P-gp) is an ATP-dependent drug efflux pump that can…

PharmaLab Congress

03. August 2016 The Event for all pharmaceutical laboratory areas will take place on 8 and 9 November 2016 in Düsseldorf for the fourth time. More Information & Registration
Read More...